Zhang Xuan, Chen Qian, Chen Bo, Wang Fangqin, Chen Xiao-Hong
Department of Pharmacology, Third Military Medical University (Army Medical University), Chongqing 400038, China.
Biomedical Analysis Center, Third Military Medical University (Army Medical University), Chongqing 400038, China.
Evid Based Complement Alternat Med. 2018 Jun 13;2018:5896398. doi: 10.1155/2018/5896398. eCollection 2018.
Herb mixtures are widely used for treatment of the menopausal syndrome long before the hormonal therapy. However, there is insufficient data for herb remedies in treating menopausal syndromes. Here we aim to investigate the effect of ZhenRongDan (ZRD) in balancing female hormones, regulating expression of estrogen receptors (ERs), and preventing organ atrophy in menopausal rats. Rats that underwent bilateral ovariectomy were used in the experiments; the effects of ZRD on serum follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin (PRL), and estradiol (E2) levels were observed. Histology of vagina and ERs expression in vagina, uterus, and adrenal gland were also examined. ELISAs were used to analyze the changes of FSH, LH, PRL, and E2 in serum, and the morphological changes of the cervical epithelium cells were observed by Hematoxylin & Eosin (H&E) staining. Immunohistochemistry and western blot were applied to detect estrogen receptors subtypes alpha (ER) and beta (ER) expression in vagina, uterus, and adrenal gland. We found that ZRD could significantly reduce the weight of the adrenal gland and increase the weight of the uterus. It could decrease the release of FSH and LH as well as increasing E2 and PRL levels. Furthermore, ZRD could improve the number of cervical vaginal epithelial cells and increase the thickness of the vaginal wall. And the altered expressions of ER and ER are also restored by ZRD. ZRD could obviously relieve the endocrine disorders, modulate organ atrophy, and restore ER and ER expression in the ovariectomized rat model.
早在激素疗法出现之前,草药混合物就被广泛用于治疗更年期综合征。然而,关于草药疗法治疗更年期综合征的数据并不充分。在此,我们旨在研究振荣丹(ZRD)在平衡雌性激素、调节雌激素受体(ERs)表达以及预防更年期大鼠器官萎缩方面的作用。实验采用双侧卵巢切除的大鼠;观察ZRD对血清促卵泡激素(FSH)、促黄体生成素(LH)、催乳素(PRL)和雌二醇(E2)水平的影响。还检查了阴道的组织学以及阴道、子宫和肾上腺中ERs的表达。采用酶联免疫吸附测定法(ELISAs)分析血清中FSH、LH、PRL和E2的变化,通过苏木精-伊红(H&E)染色观察宫颈上皮细胞的形态变化。应用免疫组织化学和蛋白质印迹法检测阴道、子宫和肾上腺中雌激素受体亚型α(ERα)和β(ERβ)的表达。我们发现,ZRD可显著减轻肾上腺重量并增加子宫重量。它可降低FSH和LH的释放,同时提高E2和PRL水平。此外,ZRD可增加宫颈阴道上皮细胞数量并增厚阴道壁。而且ZRD还可恢复ERα和ERβ的表达变化。在去卵巢大鼠模型中,ZRD可明显缓解内分泌紊乱、调节器官萎缩并恢复ERα和ERβ的表达。